Pendal Group LTD Iqvia Holdings Inc. Transaction History

Pendal Group LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 18, 2022	BUY	$181.14 - $248.26 $447,053 - $612,705	2,468 New	2,468 $447,000
Q4 2021 Jan 18, 2022	SELL	$238.37 - $282.61 $323,468 - $383,501	-1,357 Closed	0 $0
Q3 2021 Nov 05, 2021	SELL	$239.54 - $265.23 $28,744 - $31,827	-120 Reduced 8.12%	1,357 $325,000
Q2 2021 Jul 28, 2021	BUY	$198.06 - $246.77 $292,534 - $364,479	1,477 New	1,477 $358,000
Q1 2021 May 03, 2021	SELL	$173.0 - $194.59 $221,267 - $248,880	-1,279 Closed	0 $0
Q4 2020 Jan 21, 2021	BUY	$153.99 - $180.39 $196,953 - $230,718	1,279 New	1,279 $229,000
Q1 2020 May 04, 2020	SELL	$84.0 - $166.11 $88,704 - $175,412	-1,056 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$137.59 - $155.95 $145,295 - $164,683	1,056 New	1,056 $163,000
Q1 2019 May 01, 2019	SELL	$109.96 - $144.45 $1.19 Million - $1.56 Million	-10,816 Closed	0 $0
Q4 2018 Jan 30, 2019	SELL	$105.7 - $130.35 $2.07 Million - $2.55 Million	-19,577 Reduced 64.41%	10,816 $1.26 Million
Q3 2018 Nov 05, 2018	BUY	$99.3 - $130.77 $3.02 Million - $3.97 Million	30,393 New	30,393 $0

1,143

142M

828K

951K

Ticker IQV
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 185,740,000
Market Cap $36.6B
Description
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The ...

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

Stay updated on Pendal Group LTD with notifications on news.